Franco Franceschini

InstitutionUniversity of Brescia
AddressBrescia
Italy
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 11 Covid-19 publications, with a maximum of 3 publications in June 2020
    All Publications
    Bar chart showing 77 publications over 16 distinct years, with a maximum of 9 publications in 2014 and 2017 and 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Batticciotto A, Marotto D, Giorgi V, Balzarini P, Favalli EG, Balduzzi S, Fredi M, Bazzani C, Sartorelli S, Ravagnani V, Tamanini S, Castelnovo L, Lurati AM, Farah S, Bongiovanni S, Caporali R, Dagna L, Faggioli P, Franceschini F, Montecucco CM, Salaffi F, Galli M, Cappelli A, Sarzi-Puttini P. Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection. Clin Exp Rheumatol. 2021 May-Jun; 39(3):695. PMID: 33635224.
      Citations:    Fields:    Translation:HumansPHPublic Health
    2. Piantoni S, Andreoli L, Colombo E, Mendeni M, Ghirardelli ML, Brucato A, Imazio M, Furloni R, Franceschini F, Airó P, Scarsi M. Response to: 'Correspondence on 'Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome'' by Kawada. Ann Rheum Dis. 2021 Jan 27. PMID: 33504480.
      Citations: 1     Fields:    
    3. Borghi MO, Beltagy A, Garrafa E, Curreli D, Cecchini G, Bodio C, Grossi C, Blengino S, Tincani A, Franceschini F, Andreoli L, Lazzaroni MG, Piantoni S, Masneri S, Crisafulli F, Brugnoni D, Muiesan ML, Salvetti M, Parati G, Torresani E, Mahler M, Heilbron F, Pregnolato F, Pengo M, Tedesco F, Pozzi N, Meroni PL. Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome. Front Immunol. 2020; 11:584241. PMID: 33178218.
      Citations: 36     Fields:    Translation:Humans
    4. Sarzi-Puttini P, Marotto D, Caporali R, Montecucco CM, Favalli EG, Franceschini F, Fredi M, Balduzzi S, Bazzani C, Bongiovanni S, Giorgi V, Batticciotto A, Cappelli A, Balzarini P, Dagna L, Sartorelli S, Ravagnani V, Tamanini S, Farah S, Faggioli P, Castelnovo L, Lurati AM, Galli M, Salaffi F. Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study. J Autoimmun. 2021 01; 116:102545. PMID: 32972804.
      Citations: 9     Fields:    Translation:Humans
    5. Lazzaroni MG, Piantoni S, Masneri S, Garrafa E, Martini G, Tincani A, Andreoli L, Franceschini F. Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system. Blood Rev. 2021 03; 46:100745. PMID: 32868115.
      Citations: 31     Fields:    Translation:Humans
    6. Scarsi M, Piantoni S, Colombo E, Airó P, Richini D, Miclini M, Bertasi V, Bianchi M, Bottone D, Civelli P, Cotelli MS, Damiolini E, Galbassini G, Gatta D, Ghirardelli ML, Magri R, Malamani P, Mendeni M, Molinari S, Morotti A, Salada L, Turla M, Vender A, Tincani A, Brucato A, Franceschini F, Furloni R, Andreoli L. Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome. Ann Rheum Dis. 2020 10; 79(10):1286-1289. PMID: 32732245.
      Citations: 43     Fields:    Translation:HumansCellsPHPublic Health
    7. Piantoni S, Patroni A, Toniati P, Furloni R, Franceschini F, Andreoli L, Scarsi M. Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease. Rheumatology (Oxford). 2020 07 01; 59(7):1769-1770. PMID: 32472681.
      Citations: 6     Fields:    Translation:HumansCellsPHPublic Health
    8. Garrafa E, Brugnoni D, Barbaro M, Andreoli L, Focà E, Salvetti M, Castelli F, Franceschini F, Piva S, Muiesan ML, Latronico N, Levaggi R. Laboratory considerations amidst the coronavirus disease 2019 outbreak: the Spedali Civili in Brescia experience. Bioanalysis. 2020 Sep; 12(17):1223-1230. PMID: 32573254.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    9. Piantoni S, Colombo E, Airò P, Tincani A, Brucato A, Franceschini F, Andreoli L, Furloni R, Scarsi M. The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al. Clin Rheumatol. 2020 08; 39(8):2489-2490. PMID: 32564213.
      Citations: 7     Fields:    Translation:HumansCellsPHPublic Health
    10. Fredi M, Cavazzana I, Moschetti L, Andreoli L, Franceschini F. COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control study. Lancet Rheumatol. 2020 Sep; 2(9):e549-e556. PMID: 32838307.
      Citations: 39     
    11. Toniati P, Piva S, Cattalini M, Garrafa E, Regola F, Castelli F, Franceschini F, Airò P, Bazzani C, Beindorf EA, Berlendis M, Bezzi M, Bossini N, Castellano M, Cattaneo S, Cavazzana I, Contessi GB, Crippa M, Delbarba A, De Peri E, Faletti A, Filippini M, Filippini M, Frassi M, Gaggiotti M, Gorla R, Lanspa M, Lorenzotti S, Marino R, Maroldi R, Metra M, Matteelli A, Modina D, Moioli G, Montani G, Muiesan ML, Odolini S, Peli E, Pesenti S, Pezzoli MC, Pirola I, Pozzi A, Proto A, Rasulo FA, Renisi G, Ricci C, Rizzoni D, Romanelli G, Rossi M, Salvetti M, Scolari F, Signorini L, Taglietti M, Tomasoni G, Tomasoni LR, Turla F, Valsecchi A, Zani D, Zuccalà F, Zunica F, Focà E, Andreoli L, et al. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020 Jul; 19(7):102568. PMID: 32376398.
      Citations: 325     Fields:    Translation:HumansCellsPHPublic Health
    Franceschini's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (127)
    Explore
    _
    Co-Authors (153)
    Explore
    _
    Similar People (60)
    Explore
    _